A paper utilizing our Repertoire Analysis was published by Dr. Yohei Funakoshi and Dr. Kimikazu Yakushijin, the Department of Medicine, Division of Medical Oncology/Hematology, Kobe University Hospital and Graduate School of Medicine, and Dr. Goh Ohji, the Department of Microbiology and Infectious Diseases, Division of Infection Disease Therapeutics, Kobe University Hospital.
In this paper, they evaluated the Omicron XBB.1.5 mRNA vaccine using a new novel coronavirus-specific antibody sequence quantification method developed in the laboratory (QASAS method), and the results suggest that antibody production against the Omicron XBB strain is stronger than that of previous vaccines.
Our BCR Repertoire Analysis is used to obtain antibody gene sequences for matching against the novel coronavirus-specific antibody database.

eJHaem
Analysis of B-cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines

To "Publications" page